01 9BOEHRINGER INGELHEIM
01 910022379
01 9Blank
01 4Y
02 5Blank
01 92029-04-02
Patent Expiration Date : 2029-04-02
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10022379
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-2339
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-02
Patent Expiration Date : 2029-04-02
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10022379
Drug Substance Claim :
Drug Product Claim :
Application Number : 208026
Patent Use Code : U-2339
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-02
Patent Expiration Date : 2029-04-02
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10022379
Drug Substance Claim :
Drug Product Claim :
Application Number : 208026
Patent Use Code : U-2339
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-02
Patent Expiration Date : 2029-04-02
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10022379
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2732
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-02
Patent Expiration Date : 2029-04-02
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10022379
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2732
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-02
Patent Expiration Date : 2029-04-02
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10022379
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-2339
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-02
Patent Expiration Date : 2029-04-02
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10022379
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2732
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-02
Patent Expiration Date : 2029-04-02
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10022379
Drug Substance Claim :
Drug Product Claim :
Application Number : 201281
Patent Use Code : U-2339
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-02
Patent Expiration Date : 2029-04-02
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10022379
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2732
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-04-02
